Marshall Wace
WVE icon

Marshall Wace’s Wave Life Sciences WVE Stock Holding History

Marshall Wace’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Buy
+1,789,882
New +$23.3M 0.01% 857
2025
Q4 		– Sell
-14,000
Closed -$102K – 3548
2025
Q3 		$102K Sell
14,000
-10,828
-44% -$87.6K ﹤0.01% 2656
2025
Q2 		$161K Buy
+24,828
New +$164K ﹤0.01% 2490
2025
Q1 		– Sell
-183,875
Closed -$2.27M – 3146
2024
Q4 		$2.27M Buy
183,875
+55,325
+43% +$738K ﹤0.01% 1383
2024
Q3 		$1.05M Buy
128,550
+66,448
+107% +$397K ﹤0.01% 1631
2024
Q2 		$310K Sell
62,102
-251,303
-80% -$1.43M ﹤0.01% 2141
2024
Q1 		$1.93M Sell
313,405
-186,804
-37% -$935K ﹤0.01% 1379
2023
Q4 		$2.53M Buy
500,209
+318,571
+175% +$1.7M ﹤0.01% 1128
2023
Q3 		$1.04M Sell
181,638
-42,518
-19% -$194K ﹤0.01% 1488
2023
Q2 		$816K Sell
224,156
-145,334
-39% -$587K ﹤0.01% 1804
2023
Q1 		$1.6M Buy
369,490
+42,040
+13% +$193K ﹤0.01% 1575
2022
Q4 		$2.29M Buy
+327,450
New +$1.51M 0.01% 1654
2020
Q4 		– Sell
-46,481
Closed -$395K – 2221
2020
Q3 		$395K Buy
+46,481
New +$509K ﹤0.01% 1297
2019
Q2 		– Sell
-59,629
Closed -$2.32M – 1903
2019
Q1 		$2.32M Buy
+59,629
New +$2.42M 0.02% 698
2017
Q1 		– Sell
-29,822
Closed -$780K – 779
2016
Q4 		$780K Buy
+29,822
New +$970K 0.01% 789

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Marshall Wace's WVE Position: Q1 2026 in Review

Marshall Wace opened a new position in Wave Life Sciences (WVE) in Q1 2026: 1,789,882 shares worth $13M. The stake represents 0.01% of the portfolio and ranks #857 among its holdings. This is a return to the name: Marshall Wace previously reported a position in WVE as recently as Q3 2025.

Marshall Wace first reported a position in WVE in Q4 2016 and has held it in 15 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Marshall Wace held 1,789,882 shares of Wave Life Sciences worth $13M as of Q1 2026.
  • Wave Life Sciences was a new Marshall Wace position in Q1 2026.
  • Wave Life Sciences made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #857 holding.
  • Marshall Wace first reported a position in Wave Life Sciences in Q4 2016 and has held it in 15 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.